Among 58 pharmaceutical stocks, 34 stocks’ ranks ascended
Pharmaceutical stocks are raging in the securities market.
While 8 pharma companies entered the top 100 in market capitalization, 7 stocks’ ranks rose compared to the end of July except for Samsung Biologics, the leader.
According to the Korea Exchange (KRX), 34 stocks’ ranks ascended among 58 pharma stocks in the securities market.
Shin poong rallied from 2020 and is at 35th in the pharmaceutical securities market, and Korea United Pharma (285th in July) and GeneOne Life Science (286th in July) went into 200th.
By stock, Orientbio Inc. soared 253 steps than the past month, Wooridul Pharma 166 steps, Green Cross Holdings Corp. 146 steps, and GeneOne Life Science 136 steps.
Korea United Pharma climbed 98 steps, CKD Bio Corp. 70 steps, and Kukje Pharma 60 steps.
Furthermore, Reyon Pharma and Yuyu Pharma Inc. rose 46 steps and 40 steps, followed by Hana Pharma 37 steps, Ildong Holdings 34 steps, and Ildong Pharma, Jeil Pharma Holdings, Shin poong Pharma, Chong Kun Dang Pharma by over 20 steps.
Hanmi Science Co., Daewoong Pharma, Samil Pharma, JW Pharma, MyungMoon Pharma, Shin poong Pharma. Pfd. Series 1 and Hanmi Pharma advanced ten or more steps.
Kyongbo Pharma, Dong-A Socio Holdings, Hyundai Pharma, Handok, Hanall Bio Pharma, Bukwang Pharma, Whan in Pharma, Yuhan Corp., and Celltrion edged up.
In contrast, Samsung Pharma dropped 27 steps, Ilyang Pharma Pfd. Series 1 25 steps, Dong Wha Pharma and Yuhan Corp. Pfd. Series 1 14 steps, Boryung Pharma, Chong Kun Dang Holdings Corp., and JW LifeScience 10 steps.
The rankings of Pharmicell, JW Holdings, Dongsung Pharma, Daewon Pharma, Jeil Pharma, Yuyu Pharma Inc. Pfd. Series 1, Samjin Pharma, Dong-A ST, Yuyu Pharma Inc. Pfd. Series 2 and Ilsung Pharma edged down.
Although Samsung Biologics retreated a step, it is still at the head of pharmaceutical stocks.
Celltrion and Shin poong Pharma are ranked 6th and 35th, Yuhan Corp. 54th, Hanmi Science 58th, Hanmi Pharma 61st, Green Cross Corp. 75th, and Bukwang Pharma entered the top 100 with 91st.
Chong Kun Dang Pharma and Daewoong came close to 100 by 107th and 110th, followed by Hanall Bio Pharma 118th, Ilyang Pharma 128th, Daewoong Pharma 142nd, Pharmicell 144th, Green Cross Holdings 148th, and GeneOne Life Science 150th.
Between 150th and 200th, Yungjin Pharma is at 153rd, Jeil Pharma 185th, Korea United Pharma 187th, Dong-A ST 190th, JW Pharma Corp. 191st, and Boryung Pharma 197th.
Dong-A Socio Holdings Co., Dong Wha Pharma, Aprogen Pharma, Chong Kun Dang Holdings, Handok, Kwang Dong Pharma, Ildong Pharma, Hana Pharma, Daewon Pharma, Jeil Pharma Holdings, and Samjin Pharma are placed in 200th~300th.
Shin poong Pharma Pfd. Series 1 Reyon Pharma, JW Holdings, DongSung Pharma, CKD Bio Corp, JW Life Science, Whan In Pharma, Kyongbo Pharma, Wooridul Pharma, Kukje Pharma, and Samsung Pharma are in the range of 300th~400th.
For 400th~500th, Ilsung Pharma, MyungMoon Pharma, Hyundai Pharma, and Orientbio are located, and Green Cross Holdings Corp. Pfd. Series 2, Samil Pharma, Ildong Holdings, Yuyu Pharma Inc., Yuhan Corp. Pfd. Series1, Ilyang Pharma Pfd. Series 1, Yuyu Pharma Inc. Pfd. Series 1, JW Pharma Corp. Pfd. Series1, JW Pharma Corp. Pfd. Series 2, and Yuyu Pharma Inc. Pfd. Series 2 remained outside from 500th.